The NIMML Institute ("NIMML"), a 501 (c)(3) nonprofit research institute dedicated to the discovery of novel precision medicines for infectious, inflammatory and autoimmune diseases, today announced ...
Objective SLE is a heterogeneous systemic autoimmune disease with diverse clinical manifestations. We aimed to identify ...